UA97663C2 - Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения - Google Patents

Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения

Info

Publication number
UA97663C2
UA97663C2 UAA200910897A UAA200910897A UA97663C2 UA 97663 C2 UA97663 C2 UA 97663C2 UA A200910897 A UAA200910897 A UA A200910897A UA A200910897 A UAA200910897 A UA A200910897A UA 97663 C2 UA97663 C2 UA 97663C2
Authority
UA
Ukraine
Prior art keywords
promoting
development
bifidobacterium lactis
intestinal microbiota
caesarean section
Prior art date
Application number
UAA200910897A
Other languages
English (en)
Ukrainian (uk)
Inventor
Карл-Йозеф Хубер-Хааг
Мари-Клер Фишот
Флоренс Рошат
Норберт Спренгер
Original Assignee
Нестек С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Нестек С.А. filed Critical Нестек С.А.
Publication of UA97663C2 publication Critical patent/UA97663C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pediatric Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Применение Bifidobacterium lactis CNCM I-3446 в производстве лекарственного средства или лекарственной пищевой композиции в качестве стимулятора развития начальной бифидогенной кишечной микробиоты или в качестве средства для снижения риска дальнейшего развития аллергии, или в качестве средства для предупреждения или лечения диареи у детей, родившихся путем кесарева сечения. Дополнительно может содержать смесь олигосахаридов.
UAA200910897A 2007-03-28 2008-03-27 Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения UA97663C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07105074A EP1974743A1 (en) 2007-03-28 2007-03-28 Probiotics to Improve Gut Microbiota
PCT/EP2008/053611 WO2008116892A1 (en) 2007-03-28 2008-03-27 Probiotics to improve gut microbiota

Publications (1)

Publication Number Publication Date
UA97663C2 true UA97663C2 (ru) 2012-03-12

Family

ID=38051788

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA200910896A UA97662C2 (ru) 2007-03-28 2008-03-27 Применение синбиотика для улучшения кишечной микробиоты у детей, родившихся путем кесаревого сечения
UAA200910897A UA97663C2 (ru) 2007-03-28 2008-03-27 Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UAA200910896A UA97662C2 (ru) 2007-03-28 2008-03-27 Применение синбиотика для улучшения кишечной микробиоты у детей, родившихся путем кесаревого сечения

Country Status (15)

Country Link
US (4) US20100150874A1 (ru)
EP (6) EP1974743A1 (ru)
CN (4) CN101646453A (ru)
AU (4) AU2008231775A1 (ru)
BR (4) BRPI0809355A2 (ru)
CA (4) CA2680093A1 (ru)
ES (2) ES2577434T3 (ru)
MX (4) MX2009009931A (ru)
MY (1) MY151137A (ru)
PL (2) PL2131859T3 (ru)
PT (2) PT2131680E (ru)
RU (4) RU2521500C2 (ru)
UA (2) UA97662C2 (ru)
WO (4) WO2008116916A1 (ru)
ZA (3) ZA200907541B (ru)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
EP1993576B1 (en) 2006-03-07 2015-10-21 Nestec S.A. Synbiotic mixture
RU2445361C2 (ru) * 2006-06-13 2012-03-20 Нестек С.А. Профилактика и лечение воспаления среднего уха с помощью непатогенных штаммов бактерий
EP2147678A1 (en) * 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
US8498729B2 (en) * 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
BRPI0922296A2 (pt) * 2008-12-05 2015-08-11 Nestec Sa Composições para o uso em recém-nascidos com baixo peso no nascimento.
EP2206506A1 (en) * 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
WO2016026684A1 (en) 2014-08-18 2016-02-25 Nestec S.A. Prebiotics for reducing the risk of obesity later in life
CA2767960A1 (en) * 2009-07-31 2011-02-03 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
EP2289527B1 (en) 2009-08-25 2018-02-21 Nestec S.A. Bifidobacterium longum and functional GI disorders
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
EP2452575A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of age-tailored nutritional formula with probiotics
EP2455387A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465507A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
CN103415295A (zh) * 2010-12-29 2013-11-27 雀巢产品技术援助有限公司 用于减少与压力相关的肠症状的纤维和益生菌
EE05750B1 (et) 2011-02-25 2015-06-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
AU2012273206B2 (en) 2011-06-20 2015-09-24 H.J. Heinz Company Brands Llc Probiotic compositions and methods
EP2797606A4 (en) 2011-08-17 2015-09-30 MicroBiome Therapeutics LLC COMPOSITION AND USE OF A FORMULATION TO INCREASE THE RELATIONSHIP OF GASTROINTESTINAL MICROBOTS IN PLANT STEM BACTERIITIES FOR MICROBOTS OF THE FIRMUCES PLANT STAMM
US9781947B2 (en) * 2011-10-18 2017-10-10 Nestec S.A. Composition for use in the promotion of magnesium absorption and/or magnesium retention
WO2013080561A1 (en) 2011-12-01 2013-06-06 University Of Tokyo Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
JP6115094B2 (ja) * 2012-11-15 2017-04-19 株式会社Ｇｓユアサ 蓄電素子及び蓄電素子の製造方法
US9980991B2 (en) 2013-05-10 2018-05-29 H.J. Heinz Company Brands Llc Probiotics and methods of use
MX2016006220A (es) * 2013-11-15 2016-08-08 Nestec Sa Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños nacidos por cesarea.
RU2016123515A (ru) 2013-11-15 2017-12-20 Нестек С.А. Композиции для применения в целях профилактики или лечения некротизирующего энтероколита у детей грудного и младшего возраста
US11135232B2 (en) 2013-11-15 2021-10-05 Societe Des Produits Nestle S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
RU2697650C1 (ru) * 2013-11-15 2019-08-16 Сосьете Де Продюи Нестле С.А. Композиции для профилактики или лечения аллергий у младенцев, рожденных или вскармливаемых матерями несекреторного типа, путем обеспечения фукозилированными олигосахаридами, в частности среди младенцев, подверженных риску или рожденных с помощью кесарева сечения
EP3212208B1 (en) * 2014-10-29 2021-03-03 Biogaia AB Use of l. reuteri for prevention or treatment of microbiota dysbiosis in early life
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
US20180220691A1 (en) 2015-08-04 2018-08-09 Nestec S.A. Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
WO2017043963A1 (en) * 2015-09-11 2017-03-16 N.V. Nutricia Kit of parts for stimulating microbiota health after non-natural birth
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
WO2017129644A1 (en) * 2016-01-26 2017-08-03 Nestec S.A. Compositions with specific oligosaccharides to prevent or treat allergies
CN109789174B (zh) * 2016-05-31 2022-08-12 森永乳业株式会社 脑功能改善剂
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
CN109561723A (zh) * 2016-08-04 2019-04-02 雀巢产品技术援助有限公司 用于预防、治疗非轮状病毒相关性腹泻或降低其严重程度的包含低聚糖和任选地乳双歧杆菌的混合物的营养组合物和婴儿配方食品
CN110520142A (zh) * 2017-05-05 2019-11-29 雀巢产品有限公司 婴儿腹绞痛的治疗
US11779614B2 (en) * 2017-08-04 2023-10-10 Societe Des Produits Nestle S.A. Probiotic bacteria preconditioned in a GOS-containing medium and use thereof
US20220010267A1 (en) * 2018-05-30 2022-01-13 Evolve Biosystems, Inc. Compostions and method of use for h5 competent bifidobacterium longum subsp. infantis
CN108935698A (zh) * 2018-09-11 2018-12-07 内蒙古伊利实业集团股份有限公司 一种预防小儿腹泻疾病的营养组合物及应用
CN109497271A (zh) * 2018-12-06 2019-03-22 江苏奥迈生物科技有限公司 一种提高断奶仔猪免疫力的复合饲料添加剂及其制备方法
US20220293275A1 (en) * 2019-06-11 2022-09-15 CJ Bioscience. Inc Method for detecting gut dysbiosis of infant
TWI754302B (zh) * 2019-06-21 2022-02-01 大江生醫股份有限公司 乳雙歧桿菌tci604及其代謝產物的應用
CN111053244A (zh) * 2019-12-06 2020-04-24 山东体育学院 一种基于肠道微生物的营养调节方法及系统
CN111296711A (zh) * 2020-03-31 2020-06-19 广州纽缤乐营养科技股份有限公司 一种益生菌固体饮料及其制备方法
EP4180880A1 (fr) * 2021-11-10 2023-05-17 Montres Breguet S.A. Dispositif d'affichage d'une succession d'indications d'une grandeur temporelle pour une pièce d'horlogerie
EP4536010A1 (en) * 2022-06-10 2025-04-16 DSM IP Assets B.V. Combinations comprising vitamin b2 and lactobacillus rhamnosus
WO2023237687A1 (en) * 2022-06-10 2023-12-14 Dsm Ip Assets B.V. Combinations comprising vitamin b2 and lactobacillus rhamnosus
CN120390793A (zh) 2022-11-17 2025-07-29 法国国家农业食品与环境研究院 黏膜乳杆菌和需要glp-1增加的疾病
EP4660294A1 (en) * 2023-02-01 2025-12-10 Beijing Sanyuan Foods Co., Ltd. Breast milk-derived lacticaseibacillus rhamnosus and use
CN121450551A (zh) * 2026-01-07 2026-02-03 善恩康生物科技（苏州）有限公司 具有抗炎活性的沙棘源益生菌及其在肠炎治疗中的应用和产品

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
SU1743607A1 (ru) * 1990-02-05 1992-06-30 2-й Московский государственный медицинский институт им.Н.И.Пирогова Способ профилактики дисбактериоза кишечника у новорожденных детей
ES2111625T3 (es) 1992-07-06 1998-03-16 Nestle Sa Agente antigastritis.
EP0768375B2 (fr) * 1992-07-06 2002-06-12 Societe Des Produits Nestle S.A. Bactérie lactique
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
DE19958985A1 (de) * 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
WO2005000748A1 (en) 2003-06-27 2005-01-06 Bio-Circuit Aps A biogas producing facility with anaerobic hydrolysis
CA2604338A1 (en) * 2005-04-13 2006-10-19 Nestec S.A. Infant formula with probiotics
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
RU2430631C2 (ru) * 2006-02-10 2011-10-10 Нестек С.А. Пребиотическая смесь олигосахаридов и пищевой продукт, ее содержащий
EP1993576B1 (en) * 2006-03-07 2015-10-21 Nestec S.A. Synbiotic mixture
RU2445361C2 (ru) * 2006-06-13 2012-03-20 Нестек С.А. Профилактика и лечение воспаления среднего уха с помощью непатогенных штаммов бактерий

Also Published As

Publication number Publication date
ZA200907731B (en) 2011-04-28
EP2129242A1 (en) 2009-12-09
BRPI0809626A2 (pt) 2014-09-23
AU2008231778A1 (en) 2008-10-02
CA2680093A1 (en) 2008-10-02
RU2521500C2 (ru) 2014-06-27
PT2131680E (pt) 2013-10-28
EP2131680A1 (en) 2009-12-16
CN101646452A (zh) 2010-02-10
ZA200907541B (en) 2011-04-28
CA2682654A1 (en) 2008-10-02
US20100150874A1 (en) 2010-06-17
MX2009010252A (es) 2009-10-13
EP2131859B1 (en) 2016-04-27
MX2009009931A (es) 2009-09-24
BRPI0809355A2 (pt) 2014-09-02
AU2008231763B2 (en) 2013-10-31
EP1974743A1 (en) 2008-10-01
EP2489280A3 (en) 2013-06-26
WO2008116907A1 (en) 2008-10-02
CN101646453A (zh) 2010-02-10
EP2489280A2 (en) 2012-08-22
AU2008231702A1 (en) 2008-10-02
CA2678994A1 (en) 2008-03-27
UA97662C2 (ru) 2012-03-12
PL2131680T3 (pl) 2014-01-31
AU2008231763A1 (en) 2008-10-02
EP2131680B1 (en) 2013-08-14
ZA200907538B (en) 2011-04-28
WO2008116904A1 (en) 2008-10-02
PL2131859T3 (pl) 2016-12-30
CN101652079A (zh) 2010-02-17
MX2009009318A (es) 2009-09-10
US20100086527A1 (en) 2010-04-08
US20100119497A1 (en) 2010-05-13
RU2009139667A (ru) 2011-05-10
AU2008231775A1 (en) 2008-10-02
PT2131859T (pt) 2016-07-13
ES2434566T3 (es) 2013-12-16
ES2577434T3 (es) 2016-07-14
BRPI0809356A2 (pt) 2014-09-02
AU2008231702B2 (en) 2014-01-16
CN101652080A (zh) 2010-02-17
RU2456008C2 (ru) 2012-07-20
BRPI0809622A2 (pt) 2014-09-16
WO2008116892A1 (en) 2008-10-02
RU2009139658A (ru) 2011-05-10
MX2009009442A (es) 2009-09-14
MX337667B (es) 2016-03-14
RU2009139669A (ru) 2011-05-10
EP2129393A1 (en) 2009-12-09
US20100119488A1 (en) 2010-05-13
WO2008116916A1 (en) 2008-10-02
RU2009139660A (ru) 2011-05-10
CA2679081A1 (en) 2008-10-02
EP2131859A1 (en) 2009-12-16
MY151137A (en) 2014-04-30

Similar Documents

Publication Publication Date Title
UA97663C2 (ru) Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения
MY158816A (en) Probiotics for reduction of risk of obesity
MY159072A (en) Probiotics to increase iga secretion in infants born by caesarean section
MY150657A (en) Reduction of risk of diarrhoea
PH12014501749B1 (en) A nutritional composition comprising probiotics and improving sleep patterns
UA100551C2 (en) Synbiotic mixture
MY159076A (en) Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
MY196432A (en) Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health
MX2009012255A (es) Probioticos en ambiente pre y/o postquirurgico.
UA100985C2 (ru) Композиция для питания с нежизнеспособной бифидобактерией и неусваиваемым олигосахаридом
NZ601141A (en) Nutritional formulas containing synbiotics
MY169326A (en) Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
PH12013501291A1 (en) Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
IN2012DN00878A (ru)
MX2012005524A (es) Cepa de probioticos bifidobacterium.
MY191538A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
JP2009539371A5 (ru)
PH12017502182A1 (en) Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
WO2009080800A3 (en) Method for decreasing abdominal girth by administering a bifidobacterium bacteria
PH12014500185A1 (en) Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
TH117336A (th) โพรไบโอติกสำหรับลดความเสี่ยงต่อโรคอ้วน
UA52520U (ru) Способ лечения нарушений функционального состояния кишечника у новорожденных и детей младенческого возраста
AU2008902737A0 (en) Soft Human Stomach Model for In Vitro Digestive Testing
PH12013501388A1 (en) Methods of using human milk oligosaccharides for improving airway respiratory health